Filing Details
- Accession Number:
- 0001391289-12-000006
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-09-13 18:24:46
- Reporting Period:
- 2012-09-11
- Filing Date:
- 2012-09-13
- Accepted Time:
- 2012-09-13 18:24:46
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1411158 | Anacor Pharmaceuticals Inc | ANAC | Pharmaceutical Preparations (2834) | 251854385 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1239242 | E Bryan Roberts | C/O Venrock 3340 Hillview Ave. Palo Alto CA 94304 | No | No | Yes | No | |
1391289 | Venrock Associates V Lp | C/O Venrock 3340 Hillview Ave. Palo Alto CA 94304 | No | No | Yes | No | |
1395760 | P L V Partners Venrock | C/O Venrock 3340 Hillview Ave. Palo Alto CA 94304 | No | No | Yes | No | |
1444116 | Venrock Management V, Llc | C/O Venrock 3340 Hillview Ave. Palo Alto CA 94304 | No | No | Yes | No | |
1444117 | Venrock Partners Management V, Llc | C/O Venrock 3340 Hillview Ave. Palo Alto CA 94304 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2012-09-11 | 10,177 | $6.64 | 3,794,808 | No | 4 | S | Indirect | By Funds and LLC's |
Common Stock | Disposition | 2012-09-13 | 15,000 | $6.56 | 3,779,808 | No | 4 | S | Indirect | By Funds and LLC's |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | By Funds and LLC's |
No | 4 | S | Indirect | By Funds and LLC's |
Footnotes
- Consists of 1,721,350 shares held by Venrock Associates IV, L.P. ("VA4"), 351,036 shares held by Venrock Partners, L.P. ("VP"), 42,293 shares held by Venrock Entrepreneurs Fund IV, L.P. ("VEF4"), 1,361,755 shares held by Venrock Healthcare Capital Partners, L.P. ("VHCP"), 249,101 shares held by VHCP Co-Investment Holdings LLC ("VHCP Co-Invest"), 46,092 shares held by Venrock Associates V, L.P. ("VA5"), 3,908 shares held by Venrock Partners V, L.P. ("VP5"), 5,663 shares held by Venrock Management IV, LLC ("VM4"), 1,193 shares held by Venrock Partners Management, LLC ("VPM"), 82 shares held by VEF Managment IV, LLC ("VEFM4") and 12,335 shares held by VHCP Management, LLC ("VHCP Management").
- VM4, VPM, VEFM4 are the sole general partners of VA4, VP and VEF4, respectively, and may be deemed to beneficially own these shares. VHCP Management is the general partner of VHCP and the manager of VHCP Co-Invest and may be deemed to beneficially own these shares. Venrock Management V, LLC ("VM5") and Venrock Partners Management V, LLC ("VPM5") are the sole general partners of VA5 and VP5, respectively, and may be deemed to beneficially own these shares. Bryan Roberts is a member of VM4, VPM, VEFM4, VM5 and VPM5 and a managing member of VHCP Management. Dr. Roberts expressly disclaims beneficial ownership over all shares held by VA4, VP, VEF4, VA5, VP5, VHCP, VHCP Co-Invest, VM4, VPM, VEFM4, VM5, VPM5 and VHCP Management except to the extent of his indirect pecuniary interest therein.
- Consists of 1,721,350 shares held by VA4, 351,036 shares held by VP, 42,293 shares held by VEF4, 1,361,755 shares held by VHCP, 249,101 shares held by VHCP Co-Invest, 32,265 shares held by VA5, 2,735 shares held by VP5, 5,663 shares held by VM4, 1,193 shares held by VPM, 82 shares held by VEFM4 and 12,335 shares held by VHCP Management.